Boehringer Escapes Suit Over Underfilled Inhalers
A Connecticut federal judge granted Boehringer Ingelheim Pharmaceuticals Inc.'s bid to toss a class action claiming it falsely marketed a lung disease inhaler as containing twice the amount of drug that...To view the full article, register now.
Already a subscriber? Click here to view full article